002437 譽衡藥業
按盤價 
3.210 +0.010 (+0.312%)
3.210 +0.010 (+0.312%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.723 | 12.886 | 7.308 | -16.527 | 2.408 |
| 總資產報酬率 ROA (%) | 4.696 | 7.788 | 3.330 | -6.644 | 0.978 |
| 投入資產回報率 ROIC (%) | 6.442 | 10.548 | 4.311 | -8.525 | 1.291 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.293 | 53.460 | 58.389 | 56.925 | 57.528 |
| 營業利潤率 (%) | 13.813 | 11.671 | 6.666 | -8.690 | 3.049 |
| 息稅前利潤/營業總收入 (%) | 13.887 | 11.579 | 7.924 | -7.173 | 5.000 |
| 淨利潤/營業總收入 (%) | 12.499 | 9.937 | 4.901 | -9.315 | 1.712 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 79.975 | 78.232 | 77.354 | -22.987 | 54.757 |
| 價值變動淨收益/利潤總額(%) | 5.743 | -3.077 | -23.404 | 99.959 | -10.831 |
| 營業外收支淨額/利潤總額(%) | 0.142 | -0.409 | 0.979 | -0.151 | -11.540 | 償債能力分析 |
| 流動比率 (X) | 1.230 | 1.066 | 0.818 | 0.777 | 0.822 |
| 速動比率 (X) | 1.018 | 0.837 | 0.683 | 0.686 | 0.690 |
| 資產負債率 (%) | 28.698 | 30.167 | 45.749 | 58.187 | 57.852 |
| 帶息債務/全部投入資本 (%) | 3.900 | 1.620 | 29.485 | 47.661 | 47.104 |
| 股東權益/帶息債務 (%) | 2,430.353 | 5,981.618 | 234.766 | 107.551 | 110.091 |
| 股東權益/負債合計 (%) | 246.108 | 228.885 | 115.223 | 68.810 | 69.737 |
| 利息保障倍數 (X) | 253.944 | -264.700 | 6.646 | -4.769 | 2.206 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 19.561 | 24.346 | 29.737 | 26.273 | 31.902 |
| 存貨周轉天數 (天) | 55.756 | 60.111 | 66.682 | 76.131 | 97.426 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 24/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
